KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

HCA Healthcare (HCA) Net Income towards Common Stockholders (2016 - 2025)

HCA Healthcare (HCA) has disclosed Net Income towards Common Stockholders for 16 consecutive years, with $3.8 billion as the latest value for Q4 2025.

  • On a quarterly basis, Net Income towards Common Stockholders rose 167.12% to $3.8 billion in Q4 2025 year-over-year; TTM through Dec 2025 was -$4.0 billion, a 42.74% increase, with the full-year FY2025 number at $9.6 billion, up 43.97% from a year prior.
  • Net Income towards Common Stockholders was $3.8 billion for Q4 2025 at HCA Healthcare, up from -$4.8 billion in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $3.8 billion in Q4 2025 to a low of -$5.7 billion in Q4 2024.
  • A 5-year average of -$18.6 million and a median of $1.3 billion in 2022 define the central range for Net Income towards Common Stockholders.
  • Peak YoY movement for Net Income towards Common Stockholders: soared 217.33% in 2021, then tumbled 624.14% in 2024.
  • HCA Healthcare's Net Income towards Common Stockholders stood at $2.0 billion in 2021, then plummeted by 168.03% to -$1.4 billion in 2022, then skyrocketed by 42.3% to -$787.0 million in 2023, then crashed by 624.14% to -$5.7 billion in 2024, then skyrocketed by 167.12% to $3.8 billion in 2025.
  • Per Business Quant, the three most recent readings for HCA's Net Income towards Common Stockholders are $3.8 billion (Q4 2025), -$4.8 billion (Q3 2025), and -$1.5 billion (Q2 2025).